Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy.

@article{Singh2002VaginitisDT,
  title={Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy.},
  author={Shivani Singh and Jack D. Sobel and Pallavi Bhargava and Dina A. Boikov and Jose Alberto Vazquez},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2002},
  volume={35 9},
  pages={1066-70}
}
Twelve women with vaginal Candida krusei infection were evaluated. In vitro antifungal susceptibility testing and molecular typing were performed. Patients infected with C. krusei frequently had refractory vulvovaginal signs and symptoms that were otherwise indistinguishable from vaginitis due to other yeasts. Patients were 32-63 years old and had previously received multiple courses of antimycotic agents, including fluconazole and miconazole. The most active azole in vitro was clotrimazole… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Mycosis genitals. Les mycoses humaines: demarche diagnostique

  • R. Grillot
  • 1996
1 Excerpt

Similar Papers

Loading similar papers…